.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The platelet-to-white blood cell ratio (PWR) represents a significant advancement in identifying dynamic shifts in chronic inflammation within older populations. Moreover, this hematological indicator effectively tracks the balance between immune activity and clotting potential. Consequently, a lower PWR often signals higher levels of systemic inflammation, which typically precedes metabolic disorders. In addition, recent findings suggest that higher baseline PWR values significantly reduce the risk of developing type 2 diabetes (T2D). Specifically, clinicians can calculate this ratio easily during routine health check-ups to assess metabolic risk profiles.
Furthermore, a retrospective cohort study involving 7,571 older adults in China investigated this specific association. The researchers observed that participants in the highest PWR quartile enjoyed a 24% lower risk of T2D. Similarly, the study revealed an approximately linear, inverse dose-response relationship across the cohort. Thus, monitoring these blood counts provides a cost-effective strategy for early intervention in geriatric care. However, further research is necessary to validate these findings across diverse ethnic groups including those in India.
Inflammation acts as a core driver in the development of insulin resistance and beta-cell dysfunction. Therefore, markers like the PWR are invaluable because they reflect the underlying inflammatory milieu. While elevated white blood cell counts often indicate acute or chronic stress, the relative count of platelets provides context regarding systemic homeostasis. Consequently, the combination of these two values offers a more comprehensive view than either marker alone. Clinicians should therefore consider integrating this ratio into routine metabolic assessments for elderly patients.
The PWR serves as a biomarker for chronic low-grade inflammation. A higher ratio generally suggests a more balanced inflammatory state, which correlates with a lower risk of metabolic diseases like type 2 diabetes.
A higher ratio typically indicates lower white blood cell levels relative to platelets, suggesting less systemic inflammation. Because chronic inflammation is a known precursor to insulin resistance, a higher ratio identifies a lower risk profile.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sheng H et al. A community‑based study of platelet‑to‑white blood cell ratio and new‑onset type 2 diabetes in older adults. BMC Endocr Disord. 2026 Apr 13. doi: 10.1186/s12902-026-02258-2. PMID: 41975357.
Liu F, Wang T, Wang S, Zhao X, Hua Y. The association of platelet to white blood cell ratio with diabetes: a nationwide survey in China. Front Endocrinol (Lausanne). 2024 Jun 18;15:1418583. doi: 10.3389/fendo.2024.1418583. PMID: 38957446.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A high platelet-to-white blood cell ratio correlates with a 24% lower risk of developing type 2 diabetes in older adults, offering a new inflammatory marker...
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
